Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study

被引：0
|
作者：
Ho-Young Yhim
Hye Jin Kang
Yoon Hee Choi
Seok Jin Kim
Won Seog Kim
Yee Soo Chae
Jin Seok Kim
Chul Won Choi
Sung Yong Oh
Hyeon Seok Eom
Jeong-A Kim
Jae Hoon Lee
Jong-Ho Won
Hyeok Shim
Je-Jung Lee
Hwa Jung Sung
Hyo Jung Kim
Dae Ho Lee
Cheolwon Suh
Jae-Yong Kwak
机构：
[1] Chonbuk National University Medical School,Department of Internal Medicine
[2] Korea Cancer Center Hospital,Samsung Medical Center
[3] Sungkyunkwan University School of Medicine,Asan Medical Center
[4] Kyungpook National University School of Medicine,undefined
[5] Yonsei University College of Medicine,undefined
[6] Korea University Medical Center,undefined
[7] Guro Hospital,undefined
[8] Dong-A University College of Medicine,undefined
[9] National Cancer Center of Korea,undefined
[10] Catholic University of Korea College of Medicine,undefined
[11] Gachon University Gil Hospital,undefined
[12] Soonchunhyang University College of Medicine,undefined
[13] Wonkwang University School of Medicine,undefined
[14] Chonnam National University Medical School,undefined
[15] Korea University Medical Center,undefined
[16] Ansan Hospital,undefined
[17] Hallym University Medical Center and Hallym University College of Medicine,undefined
[18] University of Ulsan College of Medicine,undefined
来源：
BMC Cancer | / 10卷
关键词：
Overall Survival; International Prognostic Index; Extranodal Lymphoma; Extranodal Disease; Primary Breast Lymphoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Primary diffuse large B-cell lymphoma of the stomach: Prognostic factors and outcomes in Indian patients.
    Lewis, Shirley Christabel
    Laskar, Siddharth
    Khanna, Nehal Rishi
    Sastri, Jayant
    Menon, Hari
    Gujral, Sumeet
    Sengar, Manju
    Shet, Tanuja
    Dangi, Uma Bhaskar
    Shridhar, Epari
    Jain, Hasmukh
    Muckaden, Mary Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium
    Salles, Gilles
    de Jong, Daphne
    Xie, Wanling
    Rosenwald, Andreas
    Chhanabhai, Mukesh
    Gaulard, Philippe
    Klapper, Wolfram
    Calaminici, Maria
    Sander, Birgitta
    Thorns, Christoph
    Campo, Elias
    Molina, Thierry
    Lee, Abigail
    Pfreundschuh, Michael
    Horning, Sandra
    Lister, Andrew
    Sehn, Laurie H.
    Raemaekers, John
    Hagenbeek, Anton
    Gascoyne, Randy D.
    Weller, Edie
    BLOOD, 2011, 117 (26) : 7070 - 7078
  • [43] Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma
    Ulu, Bahar Uncu
    Yigenoglu, Tugce Nur
    Basci, Semih
    Bakirtas, Mehmet
    Sahin, Derya
    Darcin, Tahir
    Yaman, Samet
    Bozan, Ersin
    Secilmis, Sema
    Candir, Burcu Arslan
    Yildiz, Jale
    Iskender, Dicle
    Baysal, Nuran Ahu
    Cakar, Merih Kizil
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    LEUKEMIA RESEARCH, 2021, 110
  • [44] Diffuse Large B Cell Lymphoma of the Breast
    Karaca, Feryal
    Ercolak, Vehbi
    Afsar, Cigdem Usul
    Gunaldi, Meral
    CUKUROVA MEDICAL JOURNAL, 2015, 40 (01): : 151 - 157
  • [45] Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era
    Liang, Xiping
    Hu, Renzhi
    Li, Qiying
    Wang, Chaoyu
    Liu, Yao
    EXPERIMENTAL HEMATOLOGY, 2023, 122 : 1 - 9
  • [46] Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large BCell Lymphoma
    Chen, Guangliang
    Li, Dou-dou
    Sufen, Sufen
    Jiang, Shiyu
    Zhang, Qunling
    Jin, Jia
    Xia, Zuguang
    Liu, Yizhen
    Liu, Xiaojian
    Zhu, Yanzhe
    Chen, Yu
    Gu, Lingli
    Hong, Xiaonan
    Cao, Junning
    Tao, Rong
    Lv, Fangfang
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14
  • [47] Pulmonary marginal zone B-cell lymphoma of MALT type-What is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) Study
    Oh, Sung Yong
    Kim, Won Seog
    Kim, Jin Seok
    Kim, Seok Jin
    Kwon, Hyuk-Chan
    Lee, Dae Ho
    Won, Jong Ho
    Hwang, In Gyu
    Kim, Min Kyoung
    Lee, Soon Il
    Chae, Yee Soo
    Yang, Deok-Hwan
    Lee, Gyeong-Won
    Choi, Chul Won
    Park, Jinny
    Suh, Cheolwon
    Kim, Hyo-Jin
    ANNALS OF HEMATOLOGY, 2010, 89 (06) : 563 - 568
  • [48] Clinical Outcomes of Hematopoietic Cell Transplantation in Patients with Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma
    Wirk, Baldeep
    Burns, Linda
    Fenske, Timothy
    Hu, Zhenhuan
    Laport, Ginna G.
    Montoto, Silvia
    Maloney, David G.
    Saber, Wael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S157 - S158
  • [49] DIFFUSE LARGE CELL LYMPHOMA - PROGNOSTIC FACTORS WITH TREATMENT
    STRAUS, DJ
    WONG, G
    YAHALOM, J
    VARSOS, G
    GULATI, S
    CLARKSON, B
    LEUKEMIA, 1991, 5 : 32 - 37
  • [50] MicroRNA Is Prognostic Indicator in Patients with Diffuse Large B Cell Lymphoma
    Lahav, Meir
    Ram, Ron
    Kushnir, Michal
    Spilberg, Ofer
    Yanai, Gila Lithwick
    Beeri, Osnat
    Hoshen, Moshe
    Feinmesser, Maora
    BLOOD, 2008, 112 (11) : 299 - 300
12345